XML 44 R27.htm IDEA: XBRL DOCUMENT v3.10.0.1
Unaudited Selected Quarterly Results of Operations
12 Months Ended
Dec. 31, 2018
Quarterly Financial Data [Abstract]  
Unaudited Selected Quarterly Results of Operations
UNAUDITED SELECTED QUARTERLY RESULTS OF OPERATIONS

Summarized below is our unaudited quarterly financial data for the quarters during the years ended December 31, 2018 and 2017 (in thousands, except per share data):
 
 
 
Quarter ended 2018
 
 
December 31
 
September 30
 
June 30
 
March 31
Services and product sales revenue
 
$
173,207

 
$
182,146

 
$
175,475

 
$
170,018

Cost of services and product sales
 
125,694

 
128,179

 
123,773

 
119,318

Other operating expenses (3)
 
29,535

 
19,088

 
18,253

 
18,384

Operating income
 
17,978

 
34,879

 
33,449

 
32,316

Interest expense
 
3,634

 
3,278

 
3,296

 
3,120

Income before income tax expense
 
14,344

 
31,601

 
30,153

 
29,196

Income tax expense
 
5,750

 
9,404

 
5,020

 
5,273

Net income from continuing operations
 
8,594

 
22,197

 
25,133

 
23,923

Net income (loss) from discontinued operations
 
408

 
208

 
(328
)
 
(346
)
Net income
 
9,002

 
22,405

 
24,805

 
23,577

Net income (loss) attributable to non-controlling interest
 
167

 
(7
)
 
53

 
50

Net income attributable to Core Laboratories N.V.
 
$
8,835

 
$
22,412

 
$
24,752

 
$
23,527

 
 
 
 
 
 
 
 
 
Per share information:
 
 
 
 
 
 
 
 
Basic earnings per share (1) (2)
 
$
0.20

 
$
0.51

 
$
0.56

 
$
0.53

Diluted earnings per share (1) (2)
 
$
0.20

 
$
0.50

 
$
0.56

 
$
0.53

 
 
 
 
 
 
 
 
 
Weighted average common shares outstanding:
 
 
 
 
 
 
 
 
Basic
 
44,226

 
44,216

 
44,203

 
44,179

Diluted
 
44,401

 
44,591

 
44,493

 
44,463

 
 
 
Quarter ended 2017
 
 
December 31
 
September 30
 
June 30
 
March 31
Services and product sales revenue
 
$
170,111

 
$
162,887

 
$
158,212

 
$
156,609

Cost of services and product sales
 
119,942

 
118,361

 
113,635

 
113,021

Other operating expenses
 
17,764

 
17,857

 
17,222

 
20,049

Operating income
 
32,405

 
26,669

 
27,355

 
23,539

Interest expense
 
2,717

 
2,707

 
2,692

 
2,618

Income before income tax expense
 
29,688

 
23,962

 
24,663

 
20,921

Income tax expense
 
8,016

 
3,595

 
3,709

 
2,929

Net income from continuing operations
 
21,672

 
20,367

 
20,954

 
17,992

Net income (loss) from discontinued operations
 
(20
)
 
686

 
1,755

 
(310
)
Net income
 
21,652

 
21,053

 
22,709

 
17,682

Net income (loss) attributable to non-controlling interest
 
(39
)
 
(33
)
 
19

 
24

Net income attributable to Core Laboratories N.V.
 
$
21,691

 
$
21,086

 
$
22,690

 
$
17,658

 
 
 
 
 
 
 
 
 
Per share information:
 
 
 
 
 
 
 
 
Basic earnings per share (1) (2)
 
$
0.49

 
$
0.48

 
$
0.51

 
$
0.40

Diluted earnings per share (1) (2)
 
$
0.49

 
$
0.48

 
$
0.51

 
$
0.40

 
 
 
 
 
 
 
 
 
Weighted average common shares outstanding:
 
 
 
 
 
 
 
 
Basic
 
44,147

 
44,141

 
44,164

 
44,159

Diluted
 
44,276

 
44,332

 
44,374

 
44,347

(1)
Basic earnings per share and Diluted earnings per share are based on Net income attributable to Core Laboratories N.V.
(2)
The sum of the individual quarterly earnings per share amounts may not agree with the year-to-date earnings per share amounts as each quarterly computation is based on the weighted average number of common shares outstanding during that period.
(3)
Fourth quarter of 2018 includes charges of $9.9 million of additional stock compensation expenses. See Note 14.